Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.00
Delayed Data
As of Apr 28
 +0.04 / +4.17%
Today’s Change
0.85
Today|||52-Week Range
2.48
-31.74%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close0.96
Today’s open1.00
Day’s range0.96 - 1.00
Volume7,057
Average volume (3 months)38,471
Market cap$19.3M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+17.60%
Earnings growth (this year)-8.87%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.72

Competitors

 Today’s
change
Today’s
% change
ITUSITUS Corp-0.15-7.14%
ACSTAcasti Pharma Inc0.000.00%
EYEGEyeGate Pharmaceutic...-0.03-1.51%
ONTXOnconova Therapeutic...+0.06+2.92%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
James Garner
Chief Business Officer
Peng Leong
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts